From the Guidelines
In patients with Conn's syndrome, also known as primary aldosteronism, lab findings typically include elevated serum aldosterone levels, often exceeding 20 ng/dL, and suppressed plasma renin activity, usually below 1.0 ng/mL/h [ 1 ].
Key Lab Findings
- Hypokalemia, with serum potassium levels often below 3.5 mmol/L
- Metabolic alkalosis, with elevated serum bicarbonate levels
- Elevated aldosterone-to-renin ratio (ARR), typically above 30, which can be used as a screening test for the condition [ 1 ]
Important Considerations
- The ARR result needs to be interpreted in the context of the specific medication(s) the patient is taking [ 1 ]
- Hypokalemia is absent in the majority of cases and has a low negative predictive value for the diagnosis of primary aldosteronism [ 1 ]
- The diagnosis of primary aldosteronism generally requires a confirmatory test, such as the intravenous saline suppression test or oral salt-loading test [ 1 ]
From the Research
Lab Findings in Conn's Syndrome
The lab findings in Conn's syndrome, also known as primary aldosteronism, include:
- Elevated aldosterone levels 2, 3, 4, 5, 6
- Low plasma renin activity (PRA) 3, 4, 5, 6
- High aldosterone to renin ratio (ARR) 2, 3, 4
- Hypokalemia (low serum potassium levels) 2, 3, 4, 5, 6
- Hypernatremia (high serum sodium levels) 6
- Elevated creatinine phosphokinase (CPK) levels in cases of rhabdomyolysis 5
Diagnostic Tests
The following diagnostic tests are used to confirm primary aldosteronism:
- Measurement of the aldosterone-renin ratio (ARR) as a first screening test 2, 3, 4
- Aldosterone suppression testing to confirm inappropriate aldosterone secretion 4
- Imaging of the adrenal glands to differentiate between unilateral and bilateral adrenal disease 2
- Selective adrenal vein catheterization as the current gold standard for diagnosis 2
- Functional imaging techniques and measurement of steroid profiles as promising alternatives to adrenal vein catheterization 2
Subtype Evaluation
The following tests are used to evaluate the subtype of primary aldosteronism: